Suppr超能文献

胶质母细胞瘤的诊断与管理:全面视角

Diagnosis and Management of Glioblastoma: A Comprehensive Perspective.

作者信息

Gilard Vianney, Tebani Abdellah, Dabaj Ivana, Laquerrière Annie, Fontanilles Maxime, Derrey Stéphane, Marret Stéphane, Bekri Soumeya

机构信息

Department of Neurosurgery, Rouen University Hospital, 76000 Rouen, France.

Normandie Univ, UNIROUEN, CHU Rouen, INSERM U1245, 76000 Rouen, France.

出版信息

J Pers Med. 2021 Apr 1;11(4):258. doi: 10.3390/jpm11040258.

Abstract

Glioblastoma is the most common malignant brain tumor in adults. The current management relies on surgical resection and adjuvant radiotherapy and chemotherapy. Despite advances in our understanding of glioblastoma onset, we are still faced with an increased incidence, an altered quality of life and a poor prognosis, its relapse and a median overall survival of 15 months. For the past few years, the understanding of glioblastoma physiopathology has experienced an exponential acceleration and yielded significant insights and new treatments perspectives. In this review, through an original R-based literature analysis, we summarize the clinical presentation, current standards of care and outcomes in patients diagnosed with glioblastoma. We also present the recent advances and perspectives regarding pathophysiological bases as well as new therapeutic approaches such as cancer vaccination and personalized treatments.

摘要

胶质母细胞瘤是成人中最常见的恶性脑肿瘤。目前的治疗方法依赖于手术切除以及辅助放疗和化疗。尽管我们对胶质母细胞瘤的发病机制有了更深入的了解,但我们仍然面临着发病率上升、生活质量改变、预后不良、复发以及中位总生存期为15个月的问题。在过去的几年里,对胶质母细胞瘤生理病理学的理解呈指数级加速,并产生了重要的见解和新的治疗前景。在这篇综述中,我们通过基于R语言的原创文献分析,总结了胶质母细胞瘤患者的临床表现、当前的护理标准和治疗结果。我们还介绍了有关病理生理基础的最新进展和前景,以及癌症疫苗接种和个性化治疗等新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb48/8065751/eb03c846eff8/jpm-11-00258-g004.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验